Global Choroideremia Treatment Supply, Demand and Key Producers, 2023-2029
The global Choroideremia Treatment market size is expected to reach $ 4766.9 million by 2029, rising at a market growth of 4.8% CAGR during the forecast period (2023-2029).
Choroideremia is an X-linked chorioretinal dystrophy characterized by the diffuse, progressive degeneration of the retinal pigment epithelium (RPE), photoreceptors and choriocapillaris. It is caused by a mutation in the CHM gene and is the focus of exciting basic and clinical research.
This report studies the global Choroideremia Treatment production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Choroideremia Treatment, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Choroideremia Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Choroideremia Treatment total production and demand, 2018-2029, (K Units)
Global Choroideremia Treatment total production value, 2018-2029, (USD Million)
Global Choroideremia Treatment production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Choroideremia Treatment consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Choroideremia Treatment domestic production, consumption, key domestic manufacturers and share
Global Choroideremia Treatment production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Choroideremia Treatment production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Choroideremia Treatment production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Choroideremia Treatment market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis AG, Spark Therapeutics, Bluebird Bio Inc., Biogen, Copernicus Therapeutics, Inc., 4D Molecular Therapeutics, Wize Pharma Inc., Retina Implant AG and Hoffmann-La Roche Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Choroideremia Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Choroideremia Treatment Market, By Region:
1. How big is the global Choroideremia Treatment market?
2. What is the demand of the global Choroideremia Treatment market?
3. What is the year over year growth of the global Choroideremia Treatment market?
4. What is the production and production value of the global Choroideremia Treatment market?
5. Who are the key producers in the global Choroideremia Treatment market?
6. What are the growth factors driving the market demand?
Choroideremia is an X-linked chorioretinal dystrophy characterized by the diffuse, progressive degeneration of the retinal pigment epithelium (RPE), photoreceptors and choriocapillaris. It is caused by a mutation in the CHM gene and is the focus of exciting basic and clinical research.
This report studies the global Choroideremia Treatment production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Choroideremia Treatment, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Choroideremia Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Choroideremia Treatment total production and demand, 2018-2029, (K Units)
Global Choroideremia Treatment total production value, 2018-2029, (USD Million)
Global Choroideremia Treatment production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Choroideremia Treatment consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Choroideremia Treatment domestic production, consumption, key domestic manufacturers and share
Global Choroideremia Treatment production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Choroideremia Treatment production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Choroideremia Treatment production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Choroideremia Treatment market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis AG, Spark Therapeutics, Bluebird Bio Inc., Biogen, Copernicus Therapeutics, Inc., 4D Molecular Therapeutics, Wize Pharma Inc., Retina Implant AG and Hoffmann-La Roche Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Choroideremia Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Choroideremia Treatment Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Oral
- Intravenous
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Novartis AG
- Spark Therapeutics
- Bluebird Bio Inc.
- Biogen
- Copernicus Therapeutics, Inc.
- 4D Molecular Therapeutics
- Wize Pharma Inc.
- Retina Implant AG
- Hoffmann-La Roche Ltd
- Pixium Vision
- Merck
- Teva
1. How big is the global Choroideremia Treatment market?
2. What is the demand of the global Choroideremia Treatment market?
3. What is the year over year growth of the global Choroideremia Treatment market?
4. What is the production and production value of the global Choroideremia Treatment market?
5. Who are the key producers in the global Choroideremia Treatment market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Choroideremia Treatment Introduction
1.2 World Choroideremia Treatment Supply & Forecast
1.2.1 World Choroideremia Treatment Production Value (2018 & 2022 & 2029)
1.2.2 World Choroideremia Treatment Production (2018-2029)
1.2.3 World Choroideremia Treatment Pricing Trends (2018-2029)
1.3 World Choroideremia Treatment Production by Region (Based on Production Site)
1.3.1 World Choroideremia Treatment Production Value by Region (2018-2029)
1.3.2 World Choroideremia Treatment Production by Region (2018-2029)
1.3.3 World Choroideremia Treatment Average Price by Region (2018-2029)
1.3.4 North America Choroideremia Treatment Production (2018-2029)
1.3.5 Europe Choroideremia Treatment Production (2018-2029)
1.3.6 China Choroideremia Treatment Production (2018-2029)
1.3.7 Japan Choroideremia Treatment Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Choroideremia Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Choroideremia Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Choroideremia Treatment Demand (2018-2029)
2.2 World Choroideremia Treatment Consumption by Region
2.2.1 World Choroideremia Treatment Consumption by Region (2018-2023)
2.2.2 World Choroideremia Treatment Consumption Forecast by Region (2024-2029)
2.3 United States Choroideremia Treatment Consumption (2018-2029)
2.4 China Choroideremia Treatment Consumption (2018-2029)
2.5 Europe Choroideremia Treatment Consumption (2018-2029)
2.6 Japan Choroideremia Treatment Consumption (2018-2029)
2.7 South Korea Choroideremia Treatment Consumption (2018-2029)
2.8 ASEAN Choroideremia Treatment Consumption (2018-2029)
2.9 India Choroideremia Treatment Consumption (2018-2029)
3 WORLD CHOROIDEREMIA TREATMENT MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Choroideremia Treatment Production Value by Manufacturer (2018-2023)
3.2 World Choroideremia Treatment Production by Manufacturer (2018-2023)
3.3 World Choroideremia Treatment Average Price by Manufacturer (2018-2023)
3.4 Choroideremia Treatment Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Choroideremia Treatment Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Choroideremia Treatment in 2022
3.5.3 Global Concentration Ratios (CR8) for Choroideremia Treatment in 2022
3.6 Choroideremia Treatment Market: Overall Company Footprint Analysis
3.6.1 Choroideremia Treatment Market: Region Footprint
3.6.2 Choroideremia Treatment Market: Company Product Type Footprint
3.6.3 Choroideremia Treatment Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Choroideremia Treatment Production Value Comparison
4.1.1 United States VS China: Choroideremia Treatment Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Choroideremia Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Choroideremia Treatment Production Comparison
4.2.1 United States VS China: Choroideremia Treatment Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Choroideremia Treatment Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Choroideremia Treatment Consumption Comparison
4.3.1 United States VS China: Choroideremia Treatment Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Choroideremia Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Choroideremia Treatment Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Choroideremia Treatment Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Choroideremia Treatment Production Value (2018-2023)
4.4.3 United States Based Manufacturers Choroideremia Treatment Production (2018-2023)
4.5 China Based Choroideremia Treatment Manufacturers and Market Share
4.5.1 China Based Choroideremia Treatment Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Choroideremia Treatment Production Value (2018-2023)
4.5.3 China Based Manufacturers Choroideremia Treatment Production (2018-2023)
4.6 Rest of World Based Choroideremia Treatment Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Choroideremia Treatment Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Choroideremia Treatment Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Choroideremia Treatment Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Choroideremia Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Oral
5.2.2 Intravenous
5.3 Market Segment by Type
5.3.1 World Choroideremia Treatment Production by Type (2018-2029)
5.3.2 World Choroideremia Treatment Production Value by Type (2018-2029)
5.3.3 World Choroideremia Treatment Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Choroideremia Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Segment by Application
6.3.1 World Choroideremia Treatment Production by Application (2018-2029)
6.3.2 World Choroideremia Treatment Production Value by Application (2018-2029)
6.3.3 World Choroideremia Treatment Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Novartis AG
7.1.1 Novartis AG Details
7.1.2 Novartis AG Major Business
7.1.3 Novartis AG Choroideremia Treatment Product and Services
7.1.4 Novartis AG Choroideremia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Novartis AG Recent Developments/Updates
7.1.6 Novartis AG Competitive Strengths & Weaknesses
7.2 Spark Therapeutics
7.2.1 Spark Therapeutics Details
7.2.2 Spark Therapeutics Major Business
7.2.3 Spark Therapeutics Choroideremia Treatment Product and Services
7.2.4 Spark Therapeutics Choroideremia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Spark Therapeutics Recent Developments/Updates
7.2.6 Spark Therapeutics Competitive Strengths & Weaknesses
7.3 Bluebird Bio Inc.
7.3.1 Bluebird Bio Inc. Details
7.3.2 Bluebird Bio Inc. Major Business
7.3.3 Bluebird Bio Inc. Choroideremia Treatment Product and Services
7.3.4 Bluebird Bio Inc. Choroideremia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Bluebird Bio Inc. Recent Developments/Updates
7.3.6 Bluebird Bio Inc. Competitive Strengths & Weaknesses
7.4 Biogen
7.4.1 Biogen Details
7.4.2 Biogen Major Business
7.4.3 Biogen Choroideremia Treatment Product and Services
7.4.4 Biogen Choroideremia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Biogen Recent Developments/Updates
7.4.6 Biogen Competitive Strengths & Weaknesses
7.5 Copernicus Therapeutics, Inc.
7.5.1 Copernicus Therapeutics, Inc. Details
7.5.2 Copernicus Therapeutics, Inc. Major Business
7.5.3 Copernicus Therapeutics, Inc. Choroideremia Treatment Product and Services
7.5.4 Copernicus Therapeutics, Inc. Choroideremia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Copernicus Therapeutics, Inc. Recent Developments/Updates
7.5.6 Copernicus Therapeutics, Inc. Competitive Strengths & Weaknesses
7.6 4D Molecular Therapeutics
7.6.1 4D Molecular Therapeutics Details
7.6.2 4D Molecular Therapeutics Major Business
7.6.3 4D Molecular Therapeutics Choroideremia Treatment Product and Services
7.6.4 4D Molecular Therapeutics Choroideremia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 4D Molecular Therapeutics Recent Developments/Updates
7.6.6 4D Molecular Therapeutics Competitive Strengths & Weaknesses
7.7 Wize Pharma Inc.
7.7.1 Wize Pharma Inc. Details
7.7.2 Wize Pharma Inc. Major Business
7.7.3 Wize Pharma Inc. Choroideremia Treatment Product and Services
7.7.4 Wize Pharma Inc. Choroideremia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Wize Pharma Inc. Recent Developments/Updates
7.7.6 Wize Pharma Inc. Competitive Strengths & Weaknesses
7.8 Retina Implant AG
7.8.1 Retina Implant AG Details
7.8.2 Retina Implant AG Major Business
7.8.3 Retina Implant AG Choroideremia Treatment Product and Services
7.8.4 Retina Implant AG Choroideremia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Retina Implant AG Recent Developments/Updates
7.8.6 Retina Implant AG Competitive Strengths & Weaknesses
7.9 Hoffmann-La Roche Ltd
7.9.1 Hoffmann-La Roche Ltd Details
7.9.2 Hoffmann-La Roche Ltd Major Business
7.9.3 Hoffmann-La Roche Ltd Choroideremia Treatment Product and Services
7.9.4 Hoffmann-La Roche Ltd Choroideremia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Hoffmann-La Roche Ltd Recent Developments/Updates
7.9.6 Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.10 Pixium Vision
7.10.1 Pixium Vision Details
7.10.2 Pixium Vision Major Business
7.10.3 Pixium Vision Choroideremia Treatment Product and Services
7.10.4 Pixium Vision Choroideremia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Pixium Vision Recent Developments/Updates
7.10.6 Pixium Vision Competitive Strengths & Weaknesses
7.11 Merck
7.11.1 Merck Details
7.11.2 Merck Major Business
7.11.3 Merck Choroideremia Treatment Product and Services
7.11.4 Merck Choroideremia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Merck Recent Developments/Updates
7.11.6 Merck Competitive Strengths & Weaknesses
7.12 Teva
7.12.1 Teva Details
7.12.2 Teva Major Business
7.12.3 Teva Choroideremia Treatment Product and Services
7.12.4 Teva Choroideremia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Teva Recent Developments/Updates
7.12.6 Teva Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Choroideremia Treatment Industry Chain
8.2 Choroideremia Treatment Upstream Analysis
8.2.1 Choroideremia Treatment Core Raw Materials
8.2.2 Main Manufacturers of Choroideremia Treatment Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Choroideremia Treatment Production Mode
8.6 Choroideremia Treatment Procurement Model
8.7 Choroideremia Treatment Industry Sales Model and Sales Channels
8.7.1 Choroideremia Treatment Sales Model
8.7.2 Choroideremia Treatment Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Choroideremia Treatment Introduction
1.2 World Choroideremia Treatment Supply & Forecast
1.2.1 World Choroideremia Treatment Production Value (2018 & 2022 & 2029)
1.2.2 World Choroideremia Treatment Production (2018-2029)
1.2.3 World Choroideremia Treatment Pricing Trends (2018-2029)
1.3 World Choroideremia Treatment Production by Region (Based on Production Site)
1.3.1 World Choroideremia Treatment Production Value by Region (2018-2029)
1.3.2 World Choroideremia Treatment Production by Region (2018-2029)
1.3.3 World Choroideremia Treatment Average Price by Region (2018-2029)
1.3.4 North America Choroideremia Treatment Production (2018-2029)
1.3.5 Europe Choroideremia Treatment Production (2018-2029)
1.3.6 China Choroideremia Treatment Production (2018-2029)
1.3.7 Japan Choroideremia Treatment Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Choroideremia Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Choroideremia Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Choroideremia Treatment Demand (2018-2029)
2.2 World Choroideremia Treatment Consumption by Region
2.2.1 World Choroideremia Treatment Consumption by Region (2018-2023)
2.2.2 World Choroideremia Treatment Consumption Forecast by Region (2024-2029)
2.3 United States Choroideremia Treatment Consumption (2018-2029)
2.4 China Choroideremia Treatment Consumption (2018-2029)
2.5 Europe Choroideremia Treatment Consumption (2018-2029)
2.6 Japan Choroideremia Treatment Consumption (2018-2029)
2.7 South Korea Choroideremia Treatment Consumption (2018-2029)
2.8 ASEAN Choroideremia Treatment Consumption (2018-2029)
2.9 India Choroideremia Treatment Consumption (2018-2029)
3 WORLD CHOROIDEREMIA TREATMENT MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Choroideremia Treatment Production Value by Manufacturer (2018-2023)
3.2 World Choroideremia Treatment Production by Manufacturer (2018-2023)
3.3 World Choroideremia Treatment Average Price by Manufacturer (2018-2023)
3.4 Choroideremia Treatment Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Choroideremia Treatment Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Choroideremia Treatment in 2022
3.5.3 Global Concentration Ratios (CR8) for Choroideremia Treatment in 2022
3.6 Choroideremia Treatment Market: Overall Company Footprint Analysis
3.6.1 Choroideremia Treatment Market: Region Footprint
3.6.2 Choroideremia Treatment Market: Company Product Type Footprint
3.6.3 Choroideremia Treatment Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Choroideremia Treatment Production Value Comparison
4.1.1 United States VS China: Choroideremia Treatment Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Choroideremia Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Choroideremia Treatment Production Comparison
4.2.1 United States VS China: Choroideremia Treatment Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Choroideremia Treatment Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Choroideremia Treatment Consumption Comparison
4.3.1 United States VS China: Choroideremia Treatment Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Choroideremia Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Choroideremia Treatment Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Choroideremia Treatment Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Choroideremia Treatment Production Value (2018-2023)
4.4.3 United States Based Manufacturers Choroideremia Treatment Production (2018-2023)
4.5 China Based Choroideremia Treatment Manufacturers and Market Share
4.5.1 China Based Choroideremia Treatment Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Choroideremia Treatment Production Value (2018-2023)
4.5.3 China Based Manufacturers Choroideremia Treatment Production (2018-2023)
4.6 Rest of World Based Choroideremia Treatment Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Choroideremia Treatment Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Choroideremia Treatment Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Choroideremia Treatment Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Choroideremia Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Oral
5.2.2 Intravenous
5.3 Market Segment by Type
5.3.1 World Choroideremia Treatment Production by Type (2018-2029)
5.3.2 World Choroideremia Treatment Production Value by Type (2018-2029)
5.3.3 World Choroideremia Treatment Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Choroideremia Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Segment by Application
6.3.1 World Choroideremia Treatment Production by Application (2018-2029)
6.3.2 World Choroideremia Treatment Production Value by Application (2018-2029)
6.3.3 World Choroideremia Treatment Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Novartis AG
7.1.1 Novartis AG Details
7.1.2 Novartis AG Major Business
7.1.3 Novartis AG Choroideremia Treatment Product and Services
7.1.4 Novartis AG Choroideremia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Novartis AG Recent Developments/Updates
7.1.6 Novartis AG Competitive Strengths & Weaknesses
7.2 Spark Therapeutics
7.2.1 Spark Therapeutics Details
7.2.2 Spark Therapeutics Major Business
7.2.3 Spark Therapeutics Choroideremia Treatment Product and Services
7.2.4 Spark Therapeutics Choroideremia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Spark Therapeutics Recent Developments/Updates
7.2.6 Spark Therapeutics Competitive Strengths & Weaknesses
7.3 Bluebird Bio Inc.
7.3.1 Bluebird Bio Inc. Details
7.3.2 Bluebird Bio Inc. Major Business
7.3.3 Bluebird Bio Inc. Choroideremia Treatment Product and Services
7.3.4 Bluebird Bio Inc. Choroideremia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Bluebird Bio Inc. Recent Developments/Updates
7.3.6 Bluebird Bio Inc. Competitive Strengths & Weaknesses
7.4 Biogen
7.4.1 Biogen Details
7.4.2 Biogen Major Business
7.4.3 Biogen Choroideremia Treatment Product and Services
7.4.4 Biogen Choroideremia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Biogen Recent Developments/Updates
7.4.6 Biogen Competitive Strengths & Weaknesses
7.5 Copernicus Therapeutics, Inc.
7.5.1 Copernicus Therapeutics, Inc. Details
7.5.2 Copernicus Therapeutics, Inc. Major Business
7.5.3 Copernicus Therapeutics, Inc. Choroideremia Treatment Product and Services
7.5.4 Copernicus Therapeutics, Inc. Choroideremia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Copernicus Therapeutics, Inc. Recent Developments/Updates
7.5.6 Copernicus Therapeutics, Inc. Competitive Strengths & Weaknesses
7.6 4D Molecular Therapeutics
7.6.1 4D Molecular Therapeutics Details
7.6.2 4D Molecular Therapeutics Major Business
7.6.3 4D Molecular Therapeutics Choroideremia Treatment Product and Services
7.6.4 4D Molecular Therapeutics Choroideremia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 4D Molecular Therapeutics Recent Developments/Updates
7.6.6 4D Molecular Therapeutics Competitive Strengths & Weaknesses
7.7 Wize Pharma Inc.
7.7.1 Wize Pharma Inc. Details
7.7.2 Wize Pharma Inc. Major Business
7.7.3 Wize Pharma Inc. Choroideremia Treatment Product and Services
7.7.4 Wize Pharma Inc. Choroideremia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Wize Pharma Inc. Recent Developments/Updates
7.7.6 Wize Pharma Inc. Competitive Strengths & Weaknesses
7.8 Retina Implant AG
7.8.1 Retina Implant AG Details
7.8.2 Retina Implant AG Major Business
7.8.3 Retina Implant AG Choroideremia Treatment Product and Services
7.8.4 Retina Implant AG Choroideremia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Retina Implant AG Recent Developments/Updates
7.8.6 Retina Implant AG Competitive Strengths & Weaknesses
7.9 Hoffmann-La Roche Ltd
7.9.1 Hoffmann-La Roche Ltd Details
7.9.2 Hoffmann-La Roche Ltd Major Business
7.9.3 Hoffmann-La Roche Ltd Choroideremia Treatment Product and Services
7.9.4 Hoffmann-La Roche Ltd Choroideremia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Hoffmann-La Roche Ltd Recent Developments/Updates
7.9.6 Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.10 Pixium Vision
7.10.1 Pixium Vision Details
7.10.2 Pixium Vision Major Business
7.10.3 Pixium Vision Choroideremia Treatment Product and Services
7.10.4 Pixium Vision Choroideremia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Pixium Vision Recent Developments/Updates
7.10.6 Pixium Vision Competitive Strengths & Weaknesses
7.11 Merck
7.11.1 Merck Details
7.11.2 Merck Major Business
7.11.3 Merck Choroideremia Treatment Product and Services
7.11.4 Merck Choroideremia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Merck Recent Developments/Updates
7.11.6 Merck Competitive Strengths & Weaknesses
7.12 Teva
7.12.1 Teva Details
7.12.2 Teva Major Business
7.12.3 Teva Choroideremia Treatment Product and Services
7.12.4 Teva Choroideremia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Teva Recent Developments/Updates
7.12.6 Teva Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Choroideremia Treatment Industry Chain
8.2 Choroideremia Treatment Upstream Analysis
8.2.1 Choroideremia Treatment Core Raw Materials
8.2.2 Main Manufacturers of Choroideremia Treatment Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Choroideremia Treatment Production Mode
8.6 Choroideremia Treatment Procurement Model
8.7 Choroideremia Treatment Industry Sales Model and Sales Channels
8.7.1 Choroideremia Treatment Sales Model
8.7.2 Choroideremia Treatment Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Choroideremia Treatment Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Choroideremia Treatment Production Value by Region (2018-2023) & (USD Million)
Table 3. World Choroideremia Treatment Production Value by Region (2024-2029) & (USD Million)
Table 4. World Choroideremia Treatment Production Value Market Share by Region (2018-2023)
Table 5. World Choroideremia Treatment Production Value Market Share by Region (2024-2029)
Table 6. World Choroideremia Treatment Production by Region (2018-2023) & (K Units)
Table 7. World Choroideremia Treatment Production by Region (2024-2029) & (K Units)
Table 8. World Choroideremia Treatment Production Market Share by Region (2018-2023)
Table 9. World Choroideremia Treatment Production Market Share by Region (2024-2029)
Table 10. World Choroideremia Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Choroideremia Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Choroideremia Treatment Major Market Trends
Table 13. World Choroideremia Treatment Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Choroideremia Treatment Consumption by Region (2018-2023) & (K Units)
Table 15. World Choroideremia Treatment Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Choroideremia Treatment Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Choroideremia Treatment Producers in 2022
Table 18. World Choroideremia Treatment Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Choroideremia Treatment Producers in 2022
Table 20. World Choroideremia Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Choroideremia Treatment Company Evaluation Quadrant
Table 22. World Choroideremia Treatment Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Choroideremia Treatment Production Site of Key Manufacturer
Table 24. Choroideremia Treatment Market: Company Product Type Footprint
Table 25. Choroideremia Treatment Market: Company Product Application Footprint
Table 26. Choroideremia Treatment Competitive Factors
Table 27. Choroideremia Treatment New Entrant and Capacity Expansion Plans
Table 28. Choroideremia Treatment Mergers & Acquisitions Activity
Table 29. United States VS China Choroideremia Treatment Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Choroideremia Treatment Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Choroideremia Treatment Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Choroideremia Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Choroideremia Treatment Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Choroideremia Treatment Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Choroideremia Treatment Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Choroideremia Treatment Production Market Share (2018-2023)
Table 37. China Based Choroideremia Treatment Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Choroideremia Treatment Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Choroideremia Treatment Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Choroideremia Treatment Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Choroideremia Treatment Production Market Share (2018-2023)
Table 42. Rest of World Based Choroideremia Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Choroideremia Treatment Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Choroideremia Treatment Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Choroideremia Treatment Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Choroideremia Treatment Production Market Share (2018-2023)
Table 47. World Choroideremia Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Choroideremia Treatment Production by Type (2018-2023) & (K Units)
Table 49. World Choroideremia Treatment Production by Type (2024-2029) & (K Units)
Table 50. World Choroideremia Treatment Production Value by Type (2018-2023) & (USD Million)
Table 51. World Choroideremia Treatment Production Value by Type (2024-2029) & (USD Million)
Table 52. World Choroideremia Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Choroideremia Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Choroideremia Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Choroideremia Treatment Production by Application (2018-2023) & (K Units)
Table 56. World Choroideremia Treatment Production by Application (2024-2029) & (K Units)
Table 57. World Choroideremia Treatment Production Value by Application (2018-2023) & (USD Million)
Table 58. World Choroideremia Treatment Production Value by Application (2024-2029) & (USD Million)
Table 59. World Choroideremia Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Choroideremia Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 62. Novartis AG Major Business
Table 63. Novartis AG Choroideremia Treatment Product and Services
Table 64. Novartis AG Choroideremia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novartis AG Recent Developments/Updates
Table 66. Novartis AG Competitive Strengths & Weaknesses
Table 67. Spark Therapeutics Basic Information, Manufacturing Base and Competitors
Table 68. Spark Therapeutics Major Business
Table 69. Spark Therapeutics Choroideremia Treatment Product and Services
Table 70. Spark Therapeutics Choroideremia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Spark Therapeutics Recent Developments/Updates
Table 72. Spark Therapeutics Competitive Strengths & Weaknesses
Table 73. Bluebird Bio Inc. Basic Information, Manufacturing Base and Competitors
Table 74. Bluebird Bio Inc. Major Business
Table 75. Bluebird Bio Inc. Choroideremia Treatment Product and Services
Table 76. Bluebird Bio Inc. Choroideremia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Bluebird Bio Inc. Recent Developments/Updates
Table 78. Bluebird Bio Inc. Competitive Strengths & Weaknesses
Table 79. Biogen Basic Information, Manufacturing Base and Competitors
Table 80. Biogen Major Business
Table 81. Biogen Choroideremia Treatment Product and Services
Table 82. Biogen Choroideremia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Biogen Recent Developments/Updates
Table 84. Biogen Competitive Strengths & Weaknesses
Table 85. Copernicus Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 86. Copernicus Therapeutics, Inc. Major Business
Table 87. Copernicus Therapeutics, Inc. Choroideremia Treatment Product and Services
Table 88. Copernicus Therapeutics, Inc. Choroideremia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Copernicus Therapeutics, Inc. Recent Developments/Updates
Table 90. Copernicus Therapeutics, Inc. Competitive Strengths & Weaknesses
Table 91. 4D Molecular Therapeutics Basic Information, Manufacturing Base and Competitors
Table 92. 4D Molecular Therapeutics Major Business
Table 93. 4D Molecular Therapeutics Choroideremia Treatment Product and Services
Table 94. 4D Molecular Therapeutics Choroideremia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. 4D Molecular Therapeutics Recent Developments/Updates
Table 96. 4D Molecular Therapeutics Competitive Strengths & Weaknesses
Table 97. Wize Pharma Inc. Basic Information, Manufacturing Base and Competitors
Table 98. Wize Pharma Inc. Major Business
Table 99. Wize Pharma Inc. Choroideremia Treatment Product and Services
Table 100. Wize Pharma Inc. Choroideremia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Wize Pharma Inc. Recent Developments/Updates
Table 102. Wize Pharma Inc. Competitive Strengths & Weaknesses
Table 103. Retina Implant AG Basic Information, Manufacturing Base and Competitors
Table 104. Retina Implant AG Major Business
Table 105. Retina Implant AG Choroideremia Treatment Product and Services
Table 106. Retina Implant AG Choroideremia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Retina Implant AG Recent Developments/Updates
Table 108. Retina Implant AG Competitive Strengths & Weaknesses
Table 109. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 110. Hoffmann-La Roche Ltd Major Business
Table 111. Hoffmann-La Roche Ltd Choroideremia Treatment Product and Services
Table 112. Hoffmann-La Roche Ltd Choroideremia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 114. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 115. Pixium Vision Basic Information, Manufacturing Base and Competitors
Table 116. Pixium Vision Major Business
Table 117. Pixium Vision Choroideremia Treatment Product and Services
Table 118. Pixium Vision Choroideremia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Pixium Vision Recent Developments/Updates
Table 120. Pixium Vision Competitive Strengths & Weaknesses
Table 121. Merck Basic Information, Manufacturing Base and Competitors
Table 122. Merck Major Business
Table 123. Merck Choroideremia Treatment Product and Services
Table 124. Merck Choroideremia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Merck Recent Developments/Updates
Table 126. Teva Basic Information, Manufacturing Base and Competitors
Table 127. Teva Major Business
Table 128. Teva Choroideremia Treatment Product and Services
Table 129. Teva Choroideremia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 130. Global Key Players of Choroideremia Treatment Upstream (Raw Materials)
Table 131. Choroideremia Treatment Typical Customers
Table 132. Choroideremia Treatment Typical Distributors
Table 1. World Choroideremia Treatment Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Choroideremia Treatment Production Value by Region (2018-2023) & (USD Million)
Table 3. World Choroideremia Treatment Production Value by Region (2024-2029) & (USD Million)
Table 4. World Choroideremia Treatment Production Value Market Share by Region (2018-2023)
Table 5. World Choroideremia Treatment Production Value Market Share by Region (2024-2029)
Table 6. World Choroideremia Treatment Production by Region (2018-2023) & (K Units)
Table 7. World Choroideremia Treatment Production by Region (2024-2029) & (K Units)
Table 8. World Choroideremia Treatment Production Market Share by Region (2018-2023)
Table 9. World Choroideremia Treatment Production Market Share by Region (2024-2029)
Table 10. World Choroideremia Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Choroideremia Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Choroideremia Treatment Major Market Trends
Table 13. World Choroideremia Treatment Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Choroideremia Treatment Consumption by Region (2018-2023) & (K Units)
Table 15. World Choroideremia Treatment Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Choroideremia Treatment Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Choroideremia Treatment Producers in 2022
Table 18. World Choroideremia Treatment Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Choroideremia Treatment Producers in 2022
Table 20. World Choroideremia Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Choroideremia Treatment Company Evaluation Quadrant
Table 22. World Choroideremia Treatment Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Choroideremia Treatment Production Site of Key Manufacturer
Table 24. Choroideremia Treatment Market: Company Product Type Footprint
Table 25. Choroideremia Treatment Market: Company Product Application Footprint
Table 26. Choroideremia Treatment Competitive Factors
Table 27. Choroideremia Treatment New Entrant and Capacity Expansion Plans
Table 28. Choroideremia Treatment Mergers & Acquisitions Activity
Table 29. United States VS China Choroideremia Treatment Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Choroideremia Treatment Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Choroideremia Treatment Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Choroideremia Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Choroideremia Treatment Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Choroideremia Treatment Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Choroideremia Treatment Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Choroideremia Treatment Production Market Share (2018-2023)
Table 37. China Based Choroideremia Treatment Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Choroideremia Treatment Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Choroideremia Treatment Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Choroideremia Treatment Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Choroideremia Treatment Production Market Share (2018-2023)
Table 42. Rest of World Based Choroideremia Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Choroideremia Treatment Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Choroideremia Treatment Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Choroideremia Treatment Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Choroideremia Treatment Production Market Share (2018-2023)
Table 47. World Choroideremia Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Choroideremia Treatment Production by Type (2018-2023) & (K Units)
Table 49. World Choroideremia Treatment Production by Type (2024-2029) & (K Units)
Table 50. World Choroideremia Treatment Production Value by Type (2018-2023) & (USD Million)
Table 51. World Choroideremia Treatment Production Value by Type (2024-2029) & (USD Million)
Table 52. World Choroideremia Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Choroideremia Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Choroideremia Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Choroideremia Treatment Production by Application (2018-2023) & (K Units)
Table 56. World Choroideremia Treatment Production by Application (2024-2029) & (K Units)
Table 57. World Choroideremia Treatment Production Value by Application (2018-2023) & (USD Million)
Table 58. World Choroideremia Treatment Production Value by Application (2024-2029) & (USD Million)
Table 59. World Choroideremia Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Choroideremia Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 62. Novartis AG Major Business
Table 63. Novartis AG Choroideremia Treatment Product and Services
Table 64. Novartis AG Choroideremia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novartis AG Recent Developments/Updates
Table 66. Novartis AG Competitive Strengths & Weaknesses
Table 67. Spark Therapeutics Basic Information, Manufacturing Base and Competitors
Table 68. Spark Therapeutics Major Business
Table 69. Spark Therapeutics Choroideremia Treatment Product and Services
Table 70. Spark Therapeutics Choroideremia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Spark Therapeutics Recent Developments/Updates
Table 72. Spark Therapeutics Competitive Strengths & Weaknesses
Table 73. Bluebird Bio Inc. Basic Information, Manufacturing Base and Competitors
Table 74. Bluebird Bio Inc. Major Business
Table 75. Bluebird Bio Inc. Choroideremia Treatment Product and Services
Table 76. Bluebird Bio Inc. Choroideremia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Bluebird Bio Inc. Recent Developments/Updates
Table 78. Bluebird Bio Inc. Competitive Strengths & Weaknesses
Table 79. Biogen Basic Information, Manufacturing Base and Competitors
Table 80. Biogen Major Business
Table 81. Biogen Choroideremia Treatment Product and Services
Table 82. Biogen Choroideremia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Biogen Recent Developments/Updates
Table 84. Biogen Competitive Strengths & Weaknesses
Table 85. Copernicus Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 86. Copernicus Therapeutics, Inc. Major Business
Table 87. Copernicus Therapeutics, Inc. Choroideremia Treatment Product and Services
Table 88. Copernicus Therapeutics, Inc. Choroideremia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Copernicus Therapeutics, Inc. Recent Developments/Updates
Table 90. Copernicus Therapeutics, Inc. Competitive Strengths & Weaknesses
Table 91. 4D Molecular Therapeutics Basic Information, Manufacturing Base and Competitors
Table 92. 4D Molecular Therapeutics Major Business
Table 93. 4D Molecular Therapeutics Choroideremia Treatment Product and Services
Table 94. 4D Molecular Therapeutics Choroideremia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. 4D Molecular Therapeutics Recent Developments/Updates
Table 96. 4D Molecular Therapeutics Competitive Strengths & Weaknesses
Table 97. Wize Pharma Inc. Basic Information, Manufacturing Base and Competitors
Table 98. Wize Pharma Inc. Major Business
Table 99. Wize Pharma Inc. Choroideremia Treatment Product and Services
Table 100. Wize Pharma Inc. Choroideremia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Wize Pharma Inc. Recent Developments/Updates
Table 102. Wize Pharma Inc. Competitive Strengths & Weaknesses
Table 103. Retina Implant AG Basic Information, Manufacturing Base and Competitors
Table 104. Retina Implant AG Major Business
Table 105. Retina Implant AG Choroideremia Treatment Product and Services
Table 106. Retina Implant AG Choroideremia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Retina Implant AG Recent Developments/Updates
Table 108. Retina Implant AG Competitive Strengths & Weaknesses
Table 109. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 110. Hoffmann-La Roche Ltd Major Business
Table 111. Hoffmann-La Roche Ltd Choroideremia Treatment Product and Services
Table 112. Hoffmann-La Roche Ltd Choroideremia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 114. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 115. Pixium Vision Basic Information, Manufacturing Base and Competitors
Table 116. Pixium Vision Major Business
Table 117. Pixium Vision Choroideremia Treatment Product and Services
Table 118. Pixium Vision Choroideremia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Pixium Vision Recent Developments/Updates
Table 120. Pixium Vision Competitive Strengths & Weaknesses
Table 121. Merck Basic Information, Manufacturing Base and Competitors
Table 122. Merck Major Business
Table 123. Merck Choroideremia Treatment Product and Services
Table 124. Merck Choroideremia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Merck Recent Developments/Updates
Table 126. Teva Basic Information, Manufacturing Base and Competitors
Table 127. Teva Major Business
Table 128. Teva Choroideremia Treatment Product and Services
Table 129. Teva Choroideremia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 130. Global Key Players of Choroideremia Treatment Upstream (Raw Materials)
Table 131. Choroideremia Treatment Typical Customers
Table 132. Choroideremia Treatment Typical Distributors
LIST OF FIGURES
Figure 1. Choroideremia Treatment Picture
Figure 2. World Choroideremia Treatment Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Choroideremia Treatment Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Choroideremia Treatment Production (2018-2029) & (K Units)
Figure 5. World Choroideremia Treatment Average Price (2018-2029) & (US$/Unit)
Figure 6. World Choroideremia Treatment Production Value Market Share by Region (2018-2029)
Figure 7. World Choroideremia Treatment Production Market Share by Region (2018-2029)
Figure 8. North America Choroideremia Treatment Production (2018-2029) & (K Units)
Figure 9. Europe Choroideremia Treatment Production (2018-2029) & (K Units)
Figure 10. China Choroideremia Treatment Production (2018-2029) & (K Units)
Figure 11. Japan Choroideremia Treatment Production (2018-2029) & (K Units)
Figure 12. Choroideremia Treatment Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Choroideremia Treatment Consumption (2018-2029) & (K Units)
Figure 15. World Choroideremia Treatment Consumption Market Share by Region (2018-2029)
Figure 16. United States Choroideremia Treatment Consumption (2018-2029) & (K Units)
Figure 17. China Choroideremia Treatment Consumption (2018-2029) & (K Units)
Figure 18. Europe Choroideremia Treatment Consumption (2018-2029) & (K Units)
Figure 19. Japan Choroideremia Treatment Consumption (2018-2029) & (K Units)
Figure 20. South Korea Choroideremia Treatment Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Choroideremia Treatment Consumption (2018-2029) & (K Units)
Figure 22. India Choroideremia Treatment Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Choroideremia Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Choroideremia Treatment Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Choroideremia Treatment Markets in 2022
Figure 26. United States VS China: Choroideremia Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Choroideremia Treatment Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Choroideremia Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Choroideremia Treatment Production Market Share 2022
Figure 30. China Based Manufacturers Choroideremia Treatment Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Choroideremia Treatment Production Market Share 2022
Figure 32. World Choroideremia Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Choroideremia Treatment Production Value Market Share by Type in 2022
Figure 34. Oral
Figure 35. Intravenous
Figure 36. World Choroideremia Treatment Production Market Share by Type (2018-2029)
Figure 37. World Choroideremia Treatment Production Value Market Share by Type (2018-2029)
Figure 38. World Choroideremia Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Choroideremia Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Choroideremia Treatment Production Value Market Share by Application in 2022
Figure 41. Hospital Pharmacies
Figure 42. Retail Pharmacies
Figure 43. Online Pharmacies
Figure 44. World Choroideremia Treatment Production Market Share by Application (2018-2029)
Figure 45. World Choroideremia Treatment Production Value Market Share by Application (2018-2029)
Figure 46. World Choroideremia Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Choroideremia Treatment Industry Chain
Figure 48. Choroideremia Treatment Procurement Model
Figure 49. Choroideremia Treatment Sales Model
Figure 50. Choroideremia Treatment Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Figure 1. Choroideremia Treatment Picture
Figure 2. World Choroideremia Treatment Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Choroideremia Treatment Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Choroideremia Treatment Production (2018-2029) & (K Units)
Figure 5. World Choroideremia Treatment Average Price (2018-2029) & (US$/Unit)
Figure 6. World Choroideremia Treatment Production Value Market Share by Region (2018-2029)
Figure 7. World Choroideremia Treatment Production Market Share by Region (2018-2029)
Figure 8. North America Choroideremia Treatment Production (2018-2029) & (K Units)
Figure 9. Europe Choroideremia Treatment Production (2018-2029) & (K Units)
Figure 10. China Choroideremia Treatment Production (2018-2029) & (K Units)
Figure 11. Japan Choroideremia Treatment Production (2018-2029) & (K Units)
Figure 12. Choroideremia Treatment Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Choroideremia Treatment Consumption (2018-2029) & (K Units)
Figure 15. World Choroideremia Treatment Consumption Market Share by Region (2018-2029)
Figure 16. United States Choroideremia Treatment Consumption (2018-2029) & (K Units)
Figure 17. China Choroideremia Treatment Consumption (2018-2029) & (K Units)
Figure 18. Europe Choroideremia Treatment Consumption (2018-2029) & (K Units)
Figure 19. Japan Choroideremia Treatment Consumption (2018-2029) & (K Units)
Figure 20. South Korea Choroideremia Treatment Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Choroideremia Treatment Consumption (2018-2029) & (K Units)
Figure 22. India Choroideremia Treatment Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Choroideremia Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Choroideremia Treatment Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Choroideremia Treatment Markets in 2022
Figure 26. United States VS China: Choroideremia Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Choroideremia Treatment Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Choroideremia Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Choroideremia Treatment Production Market Share 2022
Figure 30. China Based Manufacturers Choroideremia Treatment Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Choroideremia Treatment Production Market Share 2022
Figure 32. World Choroideremia Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Choroideremia Treatment Production Value Market Share by Type in 2022
Figure 34. Oral
Figure 35. Intravenous
Figure 36. World Choroideremia Treatment Production Market Share by Type (2018-2029)
Figure 37. World Choroideremia Treatment Production Value Market Share by Type (2018-2029)
Figure 38. World Choroideremia Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Choroideremia Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Choroideremia Treatment Production Value Market Share by Application in 2022
Figure 41. Hospital Pharmacies
Figure 42. Retail Pharmacies
Figure 43. Online Pharmacies
Figure 44. World Choroideremia Treatment Production Market Share by Application (2018-2029)
Figure 45. World Choroideremia Treatment Production Value Market Share by Application (2018-2029)
Figure 46. World Choroideremia Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Choroideremia Treatment Industry Chain
Figure 48. Choroideremia Treatment Procurement Model
Figure 49. Choroideremia Treatment Sales Model
Figure 50. Choroideremia Treatment Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
